Jiankun International Berhad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Jiankun International Berhad şirketinin toplam hissedar öz sermayesi MYR83.5M ve toplam borcu MYR3.0M olup, bu da borç-öz sermaye oranını 3.6% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla MYR123.7M ve MYR40.2M dir.

Anahtar bilgiler

3.6%

Borç/özkaynak oranı

RM 3.04m

Borç

Faiz karşılama oranı	n/a
Nakit	RM 1.13m
Eşitlik	RM 83.49m
Toplam yükümlülükler	RM 40.20m
Toplam varlıklar	RM 123.68m

Son finansal sağlık güncellemeleri

Güncelleme yok

Recent updates

Jiankun International Berhad's (KLSE:JIANKUN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Feb 01

Here's Why We Think Jiankun International Berhad's (KLSE:JIANKUN) Statutory Earnings Might Be Conservative

Nov 29

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: JIANKUN 'nin kısa vadeli varlıkları ( MYR47.2M ) kısa vadeli yükümlülüklerini ( MYR34.9M ) aşıyor.

Uzun Vadeli Yükümlülükler: JIANKUN şirketinin kısa vadeli varlıkları ( MYR47.2M ) uzun vadeli yükümlülüklerini ( MYR5.3M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: JIANKUN 'nin net borç/öz sermaye oranı ( 2.3% ) tatmin edici olarak değerlendirilmektedir.

Borcun Azaltılması: JIANKUN 'nin borç/öz sermaye oranı son 5 yılda 42.8% seviyesinden 3.6% seviyesine düştü.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: JIANKUN şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: JIANKUN un, serbest nakit akışı her yıl % 45.8 oranında tarihi oranda azalmaya devam ederse bir yıldan az nakit akışı süresi vardır

Jiankun International Berhad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Recent updates

First quarter 2025 earnings released: RM0.004 loss per share (vs RM0.017 loss in 1Q 2024)

New minor risk - Revenue size

Jiankun International Berhad, Annual General Meeting, Dec 10, 2024

New major risk - Market cap size

New minor risk - Share price stability

High number of new directors

First quarter 2024 earnings released: RM0.005 loss per share (vs RM0.005 loss in 1Q 2023)

Jiankun International Berhad Announces the Re- Designation of Dato' Saiful Nizam Bin Mohd Yusoff from President to Non-Independent Non-Executive Chairman

Full year 2023 earnings released: RM0.037 loss per share (vs RM0.069 loss in FY 2022)

Jiankun International Berhad Receives Writ of Summon and Statement of Claim by Messrs. James Monteiro

Third quarter 2023 earnings released: RM0.023 loss per share (vs RM0.01 loss in 3Q 2022)

Jiankun International Berhad announced that it expects to receive MYR 19 million in funding

Second quarter 2023 earnings released: RM0.005 loss per share (vs RM0.015 loss in 2Q 2022)

Jiankun International Berhad (KLSE:JIANKUN) entered into memorandum of understanding to acquire Dermaga Science & Health Sdn. Bhd. from Dermaga Utama Sdn. Bhd for RM 13 million.

First quarter 2023 earnings released: RM0.005 loss per share (vs RM0.001 profit in 1Q 2022)

Jiankun International Berhad Appoints Low Ven Sin as Company Secretary

Full year 2022 earnings released: RM0.078 loss per share (vs RM0.013 profit in FY 2021)

Jiankun International Berhad Announces Redesignation of Saiful Nizam Bin Mohd Yusoff as Executive President

Third quarter 2022 earnings released: RM0.009 loss per share (vs RM0.006 profit in 3Q 2021)

High number of new and inexperienced directors

Jiankun International Berhad Appoints Dato' Yong Chong Long as Non Independent and Non Executive Director

Jiankun International Berhad Announces Redesignation of DATO' SAIFUL NIZAM BIN MOHD YUSOFF, D.I.M.P from Executive Director to Executive Deputy Chairman

Second quarter 2022 earnings released: RM0.015 loss per share (vs RM0.003 profit in 2Q 2021)

Jiankun International Berhad Appoints Terence Cheah Eu Lee as Independent and Non Executive Director

First quarter 2022 earnings released: EPS: RM0.001 (vs RM0.002 in 1Q 2021)

Jiankun International Berhad Appoints P Ellango A/L Ponramu as Independent and Non Executive Chairman of Nomination Committee

High number of new and inexperienced directors

Jiankun International Berhad Appoints Thien Lee Mee as Company Secretary

Jiankun International Berhad Appoints Chew Huey Yen as Independent and Non Executive Member of Nomination Committee

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Jiankun International Berhad Announces Re-Designation of Dato' Ir Lim Siang Chai to Executive Deputy Chairman

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

First quarter 2021 earnings released: EPS RM0.002 (vs RM0.012 in 1Q 2020)

Independent Non-Executive Director has left the company

New 90-day low: RM0.43

Jiankun International Berhad's (KLSE:JIANKUN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

New 90-day low: RM0.46

Jiankun International Berhad Appoints Encik Azmi Bin Osman as Chairman of Audit Committee

Jiankun International Berhad Announces Cessation of Encik Kamil Bin Abdul Rahman as Chairman of Nomination Committee

Jiankun International Berhad Announces the Appointment of Azmi Bin Osman as Independent and Non Executive and Independent Director

Jiankun International Berhad Announces Re-Designation of Lim Siang Chai from Executive Chairman to Executive Deputy Chairman

Jiankun International Berhad Announces Resignation of Datuk Lee Kian Seng as Non Executive Director

New 90-day high: RM0.58

Here's Why We Think Jiankun International Berhad's (KLSE:JIANKUN) Statutory Earnings Might Be Conservative

Third quarter 2020 earnings released: EPS RM0.016

New 90-day high: RM0.51

New 90-day high - RM0.47

First half earnings released

New 90-day high - RM0.46

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin